codeine phosphate (douglas)
douglas pharmaceuticals limited - codeine phosphate hemihydrate 15mg; - tablet - 15 mg - active: codeine phosphate hemihydrate 15mg excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water sodium starch glycolate
codeine phosphate (douglas)
douglas pharmaceuticals limited - codeine phosphate hemihydrate 30mg; - tablet - 30 mg - active: codeine phosphate hemihydrate 30mg excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water sodium starch glycolate
codeine phosphate (douglas)
douglas pharmaceuticals limited - codeine phosphate hemihydrate 60mg; - tablet - 60 mg - active: codeine phosphate hemihydrate 60mg excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water sodium starch glycolate
meropenem ranbaxy
douglas pharmaceuticals limited - meropenem trihydrate 1140mg equivalent to meropenem 1 g - powder for injection - 1 g - active: meropenem trihydrate 1140mg equivalent to meropenem 1 g excipient: sodium carbonate - for treatment, in adults and children, of the following infections caused by single or multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: - lower respiratory tract infections - urinary tract infections, including complicated infections - intra-abdominal infections - gynaecological infections, including postpartum infections - skin and skin structure infections - meningitis - empiric treatment, including initial monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients -septicaemia
meropenem ranbaxy
douglas pharmaceuticals limited - meropenem trihydrate 570mg equivalent to meropenem 500 mg - powder for injection - 500 mg - active: meropenem trihydrate 570mg equivalent to meropenem 500 mg excipient: sodium carbonate - for treatment, in adults and children, of the following infections caused by single or multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: - lower respiratory tract infections - urinary tract infections, including complicated infections - intra-abdominal infections - gynaecological infections, including postpartum infections - skin and skin structure infections - meningitis - empiric treatment, including initial monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients -septicaemia
azastrole
douglas manufacturing ltd - anastrozole - tablets film-coated - 1mg
endoscope element, sheath
verathon medical australia pty ltd - 37086 - endoscope element, sheath - single use outer sheath for glide scope video laryngoscope
stonewall herbicide
amgrow pty ltd - oryzalin - suspension concentrate - oryzalin anilide/aniline-dinitro active 500.0 g/l - herbicide - almond | amenity plantings | apple | apricot | banana | cherry | conifer - seedling stage | grape | grapefruit | macadamia nut | - barnyard grass or water grass | barnyard or water grass | blackberry nightshade | caltrop or yellow vine | deadnettle | fat hen | fumitory | guinea grass | lovegrass | paddy melon | paradoxa grass | pigeon grass | pigweed spp. | silverleaf nightshade | sow or milk thistle | spiny burrgrass, innocent weed | summer or crab grass | wireweed, knotweed or hogweed | annual lovegrass | annual phalaris | annual pigweed | annual summer grass | barnyard grass | bindy-eye | black nightshade | bullhead | bull's head | caltrop burr | canary grass | cathead | cat's-head | common sowthistle | fallopia aviculare | gentle annie | goat's-head | gooseberry melon | hedgehog grass | henbit deadnettle | munyeroo | nightshade | pigeon weed | pink weed | portulaca oleracea | prickly paddy melon | puncture vine | purple pigeon grass | purslane | setaria gracilis | setaria pallidefusca | setaria porphyrantha | setaria pumila | setaria verticillata | setaria viridis | silver-leaf nightshade | sow thistle | sowthistle | stingless nettle
prolan 500 herbicide
sipcam pacific australia pty. limited - oryzalin - suspension concentrate - oryzalin anilide/aniline-dinitro active 500.0 g/l - herbicide - almond | amenity plantings | apple | apricot | banana | cherry | common couch lawn or turf | conifer - seedling stage | grape | - barnyard grass or water grass | barnyard or water grass | blackberry nightshade | caltrop or yellow vine | chickweed | deadnettle | fat hen | fumitory | guinea grass | lovegrass | paddy melon | paradoxa grass | pigeon grass | pigweed spp. | ryegrass | silverleaf nightshade | sow or milk thistle | spiny burrgrass, innocent weed | summer or crab grass | winter grass | wireweed, knotweed or hogweed | annual blue grass | annual lovegrass | annual phalaris | annual pigweed | annual poa | annual summer grass | barnyard grass | bindy-eye | black nightshade | bullhead | bull's head | caltrop burr | canary grass | cathead | cat's-head | common chickweed | common sowthistle | fallopia aviculare | gentle annie | goat's-head | goose grass | gooseberry melon | hedgehog grass | henbit deadnettle | munyeroo | nightshade | pigeon weed | pink weed | portulaca oleracea | prickly paddy melon | puncture vine | purple pigeon grass | purslane | setaria gracilis | setaria pallidefusca | setaria porphyrantha | setaria pumila | setar
imipenem+cilastatin rbx
douglas pharmaceuticals limited - cilastatin sodium 530.7mg equivalent to 500 mg cilastatin; imipenem monohydrate 530.1mg equivalent to 500 mg imipenem - powder for injection - 500mg/500mg - active: cilastatin sodium 530.7mg equivalent to 500 mg cilastatin imipenem monohydrate 530.1mg equivalent to 500 mg imipenem excipient: sodium bicarbonate - indicated for the treatment of the following infections due to susceptible organisms: · intra-abdominal infections · lower respiratory tract infections · gynaecological infections · septicaemia · genitourinary tract infections · bone and joint infections · skin and soft tissue infections · endocarditis indicated for the treatment of mixed infections caused by susceptible strains of aerobic and anaerobic bacteria. the majority of these mixed infections are associated with contamination by faecal flora or flora originating from the vagina, skin and mouth. in these mixed infections, bacteroides fragilis is the most commonly encountered anaerobic pathogen and is usually resistant to aminoglycosides, ephalosporins and penicillins. however, bacteroides fragilis is usually susceptible to imipenem and cilastatin combination. imipenem and cilastatin combination has demonstrated efficacy against many infections caused by aerobic and anaerobic gram-positive and gram-negative bacteria resistant to the cephalosporins, including cefazolin, cefoperazone, cephalothin, cefoxitin, cefotaxime, moxalactam, cefamandole, ceftazidime and ceftriaxone. similarly, many infections caused by organisms resistant to aminoglycosides (gentamicin, amikacin, tobramycin) and/or penicillins (ampicillin, carbenicillin, penicillin-g, ticarcillin, piperacillin, azlocillin, mezlocillin) responded to treatment imipenem and cilastatin. imipenem+cilastatin rbx is not indicated for the treatment of meningitis.